Ligand validation:5AXC

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5AXC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5AXC_NAD_A_501	97%	21%	0.06	0.973	1.5	1.79	3	10	0	0	100%	1
5AXC_NAD_C_501	95%	21%	0.063	0.968	1.34	1.92	2	9	0	0	100%	1
5AXB_NAD_C_501	99%	26%	0.054	0.985	1.51	1.47	4	6	0	0	100%	1
5AXD_NAD_C_501	98%	28%	0.06	0.981	1.48	1.43	3	7	1	0	100%	1
5AXA_NAD_A_501	94%	27%	0.071	0.968	1.51	1.45	5	7	1	0	100%	1
5W4B_NAD_D_501	92%	45%	0.091	0.982	0.83	1.27	2	5	0	0	100%	1
8COD_NAD_B_601	91%	57%	0.102	0.991	0.78	0.88	1	1	2	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.